The stock has demonstrated a strong uptrend over the observed 180-day period, rising from around $66 in early October 2025 to a peak above $81 in late February 2026, representing a gain of over 23%. However, the stock has recently pulled back from its highs, with a 1-month decline of 6.76% and a 3-month gain of 8.78%, indicating a short-term consolidation phase after a significant rally. The current price of $76.05 sits approximately 7.3% below its 52-week high of $82.00 and is 16.4% above its 52-week low of $65.35, positioning it in the upper half of its yearly range, though well off the recent peak.

Revenue in the latest quarter (Q4 2025) was $11.82 billion, showing a year-over-year growth of 2.4%. Profitability remains robust with a net margin of 27.3% (trailing) and an operating margin of 28.7%, though quarterly net income of $2.27 billion was down sequentially from Q3's $3.70 billion. The company's financial health shows a debt-to-equity ratio of 1.41, indicating significant leverage, but this is supported by strong free cash flow of $5.3 billion (TTM) and a healthy current ratio of 1.46. Operational efficiency is highlighted by a very strong return on equity of 40.7% and a return on assets of 9.15%, demonstrating effective use of shareholder capital and assets.